RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Top Cited Papers
- 3 February 2010
- journal article
- Published by Springer Nature in Nature
- Vol. 464 (7287) , 431-435
- https://doi.org/10.1038/nature08833
Abstract
Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.Keywords
This publication has 33 references indexed in Scilit:
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor CellsScience, 2009
- A dimerization-dependent mechanism drives RAF catalytic activationNature, 2009
- Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant TumorsPLOS ONE, 2009
- Inhibitor hijacking of Akt activationNature Chemical Biology, 2009
- KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancerMolecular Cancer Therapeutics, 2009
- Characterization of Ser338 Phosphorylation for Raf-1 ActivationJournal of Biological Chemistry, 2008
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityProceedings of the National Academy of Sciences, 2008
- The RAF proteins take centre stageNature Reviews Molecular Cell Biology, 2004
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D-Biological Crystallography, 1994
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973